{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:02:20Z","timestamp":1789977740213,"version":"4.0.1"},"reference-count":33,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100016819","name":"Octapharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/13696998.2026.2732441","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:11:49Z","timestamp":1789974709000},"page":"2375-2385","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Cost comparison of intravenous immunoglobulin and subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyneuropathy"],"prefix":"10.1080","volume":"29","author":[{"given":"Suraj A.","family":"Muley","sequence":"first","affiliation":[{"name":"ASU School of Medicine & Advanced Medical Engineering"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Gucciardi","sequence":"additional","affiliation":[{"name":"Octapharma AG","place":["Lachen, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Kaisare","sequence":"additional","affiliation":[{"name":"Octapharma USA","place":["Paramus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wissmann","sequence":"additional","affiliation":[{"name":"Octapharma AG","place":["Lachen, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bandy","sequence":"additional","affiliation":[{"name":"AESARA Inc","place":["Chapel Hill, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Shi","family":"Yeh","sequence":"additional","affiliation":[{"name":"AESARA Inc","place":["Chapel Hill, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Myers","sequence":"additional","affiliation":[{"name":"CSI Pharmacy","place":["Nash, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/ENE.14959"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S388151"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/S00415-020-09998-8"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1159\/000494291"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/BRAIN\/AWAB422"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/JNNP.2010.206599"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/JNS.12408"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/JNS5.12017"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S185852"},{"key":"e_1_3_5_11_1","unstructured":"Hytrulo V. Boston MA argenx US Inc. 2025. Accessed 2025 December 21. [package insert]."},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00309-0"},{"key":"e_1_3_5_13_1","volume-title":"PNS 2025 Annual Meeting","volume":"503","author":"Cornblath D","year":"2025","unstructured":"Cornblath D, Wilson J, Baquie M, et al. Intravenous immunoglobulin versus subcutaneous efgartigimod for CIDP: matching-adjusted indirect comparison (P455). PNS 2025 Annual Meeting; 2025. 503. Accessed 2025 August 10. Available from: https:\/\/account.pnsociety.com\/files\/2025%20PNS%20Annual%20Meeting_Edinburgh\/2025_PNS_Abstract_Supplement_Final_2June2025.pdf."},{"key":"e_1_3_5_14_1","volume-title":"Octapharma Pharmazeutika Produktionsges.m.b.H. 2025. Accessed 2025 December 21","author":"PANZYGA [package insert]","unstructured":"PANZYGA [package insert]. Octapharma Pharmazeutika Produktionsges.m.b.H. 2025. Accessed 2025 December 21. Vienna Austria."},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2025.2604457"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/JNNP-2017-316427"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/S40120-023-00478-5"},{"key":"e_1_3_5_18_1","article-title":"Observations regarding the average sales price reimbursement methodology","volume":"27","author":"Weidner S","year":"2021","unstructured":"Weidner S, Diaz M, Schaedig C, et al. Observations regarding the average sales price reimbursement methodology. American Journal of Manage Care. 2021;27. Accessed 2025 September 25. Available from: https:\/\/www.ajmc.com\/view\/observations-regarding-the-average-sales-price-reimbursement-methodology.","journal-title":"American Journal of Manage Care"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2024.2379055"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-018-0697-3"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/MUS.24207"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/JNNP-2014-309042"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.3138\/9781487599461-022"},{"key":"e_1_3_5_24_1","unstructured":"Dose & infusion calculator. 2020. [Internet] Available from: https:\/\/www.panzyga.com\/api\/download\/x\/07539e8b9d\/panzyga-infusion-and-dose-calculator_v1-0.pdf. Accessed 26 Jul 2026."},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2024.10.183"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI97911"},{"key":"e_1_3_5_27_1","unstructured":"Allen J Vu T Gable K. Accessed 11 Aug 2025. et al. Transitioning patients from IVIg to efgartigimod. Neurology Live. 2025. Available from https:\/\/www.neurologylive.com\/view\/transitioning-patients-from-ivig-to-efgartigimod."},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2024.123313"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2026.578925"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2024.03.2264"},{"key":"e_1_3_5_31_1","unstructured":"Centers of Medicare and Medicaid Services. ASP Drug Pricing [Internet]. 2026. Available from: https:\/\/www.cms.gov\/medicare\/payment\/part-b-drugs\/asp-pricing-files. Accessed 2026 January 30."},{"key":"e_1_3_5_32_1","unstructured":"Centers for Medicare and Medicaid Services. Physician Fee Schedule. 2026. Available from https:\/\/www.cms.gov\/medicare\/payment\/fee-schedules\/physician. Accessed 2026 January 30."},{"key":"e_1_3_5_33_1","unstructured":"Pfizeriguide. Billing and Coding Information. 2024. Available from: https:\/\/www.pfizeriguideresources.com\/files\/Panzyga-Billing-and-Coding-Guide-for-FRMs.pdf. Accessed 2025 August 11."},{"key":"e_1_3_5_34_1","unstructured":"Argenx. Vyvgart Hytrulo Billing & Coding Guide. 2023. Available from https:\/\/vyvgarthcp.com\/content\/dam\/vyvgart\/hcp\/pdfs\/VYVGART-Hytrulo-Billing-and-Coding-Guide.pdf. Accessed 2025 August 11."}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2732441","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/13696998.2026.2732441","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2732441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:11:53Z","timestamp":1789974713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2026.2732441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/13696998.2026.2732441"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2026.2732441","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-07-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}